1990
DOI: 10.1097/00002826-199012000-00008
|View full text |Cite
|
Sign up to set email alerts
|

Plasma and CSF Levels of Albendazole and Praziquantel in Patients with Neurocysticercosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
24
0
2

Year Published

1992
1992
2014
2014

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 69 publications
(27 citation statements)
references
References 0 publications
1
24
0
2
Order By: Relevance
“…Survival of cysts in brain tissue may be explained by lower concentrations of the drug or reduced immune efficacies in the central nervous system because of the blood-brain barrier. 27 Pig brain is not commonly eaten raw; thus, it is highly improbable that cysts that survive only in the brain will be ingested and perpetuate the cycle.…”
Section: Resultsmentioning
confidence: 99%
“…Survival of cysts in brain tissue may be explained by lower concentrations of the drug or reduced immune efficacies in the central nervous system because of the blood-brain barrier. 27 Pig brain is not commonly eaten raw; thus, it is highly improbable that cysts that survive only in the brain will be ingested and perpetuate the cycle.…”
Section: Resultsmentioning
confidence: 99%
“…Of the two, only albendazole has been used in children with NLM. In addition, albendazole appears to have the more favorable pharmacologic profile, with good absorption, high serum concentrations of the active metabolite, good penetration across the blood-brain barrier, and minimal toxicity (11,26).…”
Section: Visceral and Neural Larva Migransmentioning
confidence: 99%
“…Serum levels of phenytoin and carbamazepine may also be lowered as the result of simultaneous praziquantel administration (12). Albendazole has better penetration into cerebrospinal fluid, its concentrations are not affected when given with steroids (61,62), and it is cheaper than praziquantel. Table 2 summarizes most trials of antiparasitic therapy for neurocysticercosis.…”
Section: Vol 15 2002 Guidelines For Treatment Of Neurocysticercosismentioning
confidence: 99%